Bio-Techne Declares Dividend
Get Alerts TECH Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +1.1%
Join SI Premium – FREE
MINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2019. The quarterly dividend will be payable May 24, 2019 to all common shareholders of record on May 10, 2019. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $643 million in net sales in fiscal 2018 and has over 2,100 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com.
Contact: | David Clair, Investor Relations |
646-277-1266 |

View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-declares-dividend-300840205.html
SOURCE Bio-Techne Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cohen & Steers Closed-End Funds Declare Distributions for July, August and September 2026
- BHMarketer.ai Announces the Launch of SpeedCheck.fyi, a Web-Based Tool Combining Network Performance Testing and IP Reputation Insights
- Hana Hou AC Heat Plumbing Electrical Launches $49 Summer A/C Tune-Up to Help Orange County Homeowners Beat the Heat and Avoid Costly Breakdowns
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share